Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Daito Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Market Capitalization	39,943	29,536	34,043	33,086	37,154	44,980
Market Cap Growth	28.41%	-13.24%	2.89%	-10.95%	-17.40%	-21.02%
Enterprise Value	48,746	37,736	37,799	34,956	37,065	46,116
Last Close Price	1366.00	969.83	1058.51	967.02	1072.91	1314.78
PE Ratio	18.38	15.48	10.33	9.19	7.96	10.59
Forward PE	17.13	8.96	8.98	9.39	8.00	10.05
PS Ratio	0.78	0.58	0.73	0.73	0.86	0.92
PB Ratio	0.77	0.57	0.65	0.65	0.78	1.07
P/TBV Ratio	0.78	0.57	0.66	0.66	0.79	1.09
P/FCF Ratio	7.38	-	-	-	-	-
P/OCF Ratio	4.25	5.01	6.57	7.96	8.50	8.68
EV/Sales Ratio	0.95	0.75	0.81	0.78	0.85	0.95
EV/EBITDA Ratio	6.71	5.43	5.00	3.85	3.75	5.08
EV/EBIT Ratio	16.80	14.40	9.71	6.71	5.64	7.80
EV/FCF Ratio	9.01	-	-	-	-	-
Debt / Equity Ratio	0.21	0.23	0.17	0.10	0.07	0.08
Debt / EBITDA Ratio	1.54	1.71	1.15	0.55	0.35	0.37
Debt / FCF Ratio	2.03	-	-	-	-	-
Asset Turnover	0.65	0.65	0.63	0.67	0.71	0.87
Inventory Turnover	2.16	2.14	1.89	1.98	1.97	2.72
Quick Ratio	1.26	1.32	1.05	1.38	1.46	1.26
Current Ratio	2.39	2.45	2.24	2.64	2.70	2.52
Return on Equity (ROE)	4.35%	3.38%	6.16%	7.15%	10.33%	10.55%
Return on Assets (ROA)	2.22%	2.10%	3.28%	4.81%	6.69%	6.60%
Return on Invested Capital (ROIC)	3.52%	2.61%	5.31%	7.31%	10.20%	10.62%
Return on Capital Employed (ROCE)	4.60%	4.30%	6.60%	9.50%	12.90%	13.20%
Earnings Yield	5.59%	6.46%	9.68%	10.88%	12.56%	9.44%
FCF Yield	13.54%	-3.02%	-3.05%	-4.08%	-0.69%	-2.53%
Dividend Yield	2.92%	3.61%	2.83%	2.82%	2.12%	1.59%
Payout Ratio	47.51%	52.31%	27.53%	25.86%	14.14%	15.50%
Buyback Yield / Dilution	2.67%	3.06%	0.86%	-3.38%	-1.94%	-6.42%
Total Shareholder Return	5.63%	6.67%	3.70%	-0.56%	0.18%	-4.83%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.